DRTS Earnings — Alpha Tau Medical Ltd. Ordinary Shares Post-ER Performance | BigEarnings
DRTS — Alpha Tau Medical Ltd. Ordinary Shares
XNAS · Healthcare · Biotechnology
Price$10.83
Market Cap$978.2M
P/E—
52W Range$2.81 – $11.62
Next Earnings2026-08-10
About Alpha Tau Medical Ltd. Ordinary Shares
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
🤖 AI Earnings Analysis
Alpha Tau's biotech operations face mounting losses with **$0.14 EPS miss** and no revenue generation, raising serious concerns about cash runway.
